Olanzapine-induced hypertriglyceridemia in cancer care: A silent metabolic risk
Olanzapine (Zyprexa), an atypical antipsychotic, is used off-label for managing nausea in advanced cancer patients but is linked to severe metabolic side effects, including hypertriglyceridemia. This case involves a metastatic gastric carcinoma patient with no known metabolic disorder who developed...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2025-03-01
|
| Seri Bilgileri: | Current Problems in Cancer: Case Reports |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2666621924000668 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|